| Primary |
| Product Used For Unknown Indication |
53.8% |
| Hypertension |
15.4% |
| Cardiac Disorder |
7.7% |
| Type 2 Diabetes Mellitus |
7.7% |
| Pain |
4.6% |
| Abdominal Discomfort |
1.5% |
| Anticoagulant Therapy |
1.5% |
| Anxiety |
1.5% |
| Blood Pressure Abnormal |
1.5% |
| Cardiac Failure |
1.5% |
| Congestive Cardiomyopathy |
1.5% |
| Haemorrhoids |
1.5% |
|
| Toxicity To Various Agents |
16.0% |
| Nausea |
8.0% |
| Presyncope |
8.0% |
| Atrial Fibrillation |
4.0% |
| Bronchostenosis |
4.0% |
| Cardiac Failure |
4.0% |
| Diabetes Mellitus |
4.0% |
| Dysstasia |
4.0% |
| Electrocardiogram Qt Prolonged |
4.0% |
| Fungal Skin Infection |
4.0% |
| Hypertension |
4.0% |
| Hypoglycaemia |
4.0% |
| Mental Status Changes |
4.0% |
| Orthostatic Hypotension |
4.0% |
| Psoriatic Arthropathy |
4.0% |
| Respiratory Tract Infection |
4.0% |
| Sinus Arrest |
4.0% |
| Sinus Bradycardia |
4.0% |
| Somnolence |
4.0% |
| Syncope |
4.0% |
|
| Secondary |
| Product Used For Unknown Indication |
49.2% |
| Pneumonia |
4.9% |
| Pneumonitis |
4.9% |
| Type 2 Diabetes Mellitus |
4.9% |
| Angina Unstable |
3.3% |
| Anticoagulant Therapy |
3.3% |
| Antiplatelet Therapy |
3.3% |
| Cardiomegaly |
3.3% |
| Essential Hypertension |
3.3% |
| Hypertension |
3.3% |
| Polyuria |
3.3% |
| Bronchitis |
1.6% |
| Cardiac Failure |
1.6% |
| Chronic Myeloid Leukaemia |
1.6% |
| Coronary Artery Disease |
1.6% |
| Diabetes Mellitus |
1.6% |
| Gastrooesophageal Reflux Disease |
1.6% |
| Heart Rate Abnormal |
1.6% |
| Neoplasm Malignant |
1.6% |
|
| Exposure Via Ingestion |
15.0% |
| Tendonitis |
15.0% |
| Completed Suicide |
10.0% |
| Renal Failure Acute |
10.0% |
| Anaphylactic Reaction |
5.0% |
| Infection |
5.0% |
| Lactose Intolerance |
5.0% |
| Pustular Psoriasis |
5.0% |
| Pyrexia |
5.0% |
| Sepsis |
5.0% |
| Somnolence |
5.0% |
| Toxicity To Various Agents |
5.0% |
| Urine Output Increased |
5.0% |
| Vision Blurred |
5.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
24.2% |
| Plasma Cell Myeloma |
15.4% |
| Nephrogenic Anaemia |
8.7% |
| Prostate Cancer |
5.4% |
| Prostate Cancer Metastatic |
5.4% |
| Rheumatoid Arthritis |
4.7% |
| Type 2 Diabetes Mellitus |
4.7% |
| Hypertension |
4.0% |
| Cardiac Failure |
3.4% |
| Chronic Myeloid Leukaemia |
3.4% |
| Gait Disturbance |
3.4% |
| Drug Use For Unknown Indication |
2.7% |
| Multiple Sclerosis |
2.7% |
| Coronary Artery Disease |
2.0% |
| Multiple Myeloma |
2.0% |
| Prophylaxis |
2.0% |
| Status Epilepticus |
2.0% |
| Actinic Keratosis |
1.3% |
| Acute Lymphocytic Leukaemia |
1.3% |
| Diabetic Nephropathy |
1.3% |
|
| Vomiting |
8.6% |
| Pancreatitis |
6.9% |
| Unresponsive To Stimuli |
6.9% |
| Weight Decreased |
6.9% |
| White Blood Cell Count Decreased |
6.9% |
| Hypertension |
5.2% |
| Myocardial Infarction |
5.2% |
| Pain In Extremity |
5.2% |
| Rectal Haemorrhage |
5.2% |
| Renal Failure Acute |
5.2% |
| Rhabdomyolysis |
5.2% |
| Urinary Tract Infection |
5.2% |
| Dyspnoea |
3.4% |
| Fatigue |
3.4% |
| Gout |
3.4% |
| Malaise |
3.4% |
| Nausea |
3.4% |
| Oedema |
3.4% |
| Pain |
3.4% |
| Pancytopenia |
3.4% |
|
